BDNF Val66Met genotype and 6-month remission rates in late-life depression
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Although not observed in younger adult cohorts, in older individuals the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with major depressive disorder (MDD) risk. It is further associated with subjective social support and magnetic resonance imaging (MRI) hyperintense lesions, clinical features independently related to MDD. We examined the relationship between this polymorphism and antidepressant remission rates in an elderly sample with MDD, while also testing for mediation effects of social support and hyperintensities. A total of 229 elderly Caucasian subjects with MDD completed baseline assessments, 1.5 T MRI, and BDNF genotyping. They received antidepressant medication under a structured treatment algorithm and were evaluated for remission at 3 and 6 months. At the 3-month evaluation, BDNF Val66Met genotype was not associated with remission (Wald's χ2=2.51, P=0.1131). When not controlling for multiple comparisons, Met66 allele carriers were more likely to be remitted at 6 months (χ2=4.32, P=0.0377) with an odds ratio of 1.82 (95% CI: 1.04, 3.22). This effect persisted after controlling for lesion volume and social support, neither of which mediated this relationship. Thus in this exploratory analysis, the Met66 allele may be associated with increased odds of remission in older subjects, but also with increased time to remission as there was no 3-month effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
The cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182
Chen, Z.-Y., Patel, P. D., Sant, G., Meng, C.-X., Teng, K. K., Hempstead, B. L., & Lee, F. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0348-04.2004 · Cited by 874
Social Support and the Outcome of Major Depression
George, L. K., Blazer, D. G., Hughes, D. C., & Fowler, N. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.4.478 · Cited by 732
Verhagen, M., van der Meij, A., van Deurzen, P. A. M., Janzing, J. G. E., Arias-Vásquez, A., Buitelaar, J. K., & Franke, B. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.109 · Cited by 470
Executive dysfunction and the course of geriatric depression
Alexopoulos, G. S., Kiosses, D. N., Heo, M., Murphy, C. F., Shanmugham, B., & Gunning-Dixon, F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.024 · Cited by 317
Cited by
Notaras, M., Hill, R., & van den Buuse, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.27 · Cited by 274
Naismith, S. L., Norrie, L. M., Mowszowski, L., & Hickie, I. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.009 · Cited by 270
Lotrich, F. E., Albusaysi, S., & Ferrell, R. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.263 · Cited by 92
“The BDNF Met allele could be associated with better response to SSRIs (Su et al, 2011; Taylor et al, 2011; Zhang et al, 2011), and suicidal ideation is the least common residual symptom following SSRI treatment (McClintock et al, 2011).”
BackgroundInvolvement of Brain-Derived Neurotrophic Factor in Late-Life Depression
Dwivedi, Y. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.026 · Cited by 86
Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications
Fabbri, C., & Serretti, A. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0594-9 · Cited by 84
Pei, Y., Smith, A. K., Wang, Y., Pan, Y., Yang, J., Chen, Q., Pan, W., Bao, F., Zhao, L., Tie, C., et al. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32062 · Cited by 67
“…on geriatric depression [von Bohlen und Halbach et al., 2006; Hayden et al., 2010; Hedner et al., 2010; Erickson et al., 2011], three review articles [ArantesGoncalves and Coelho, 2006; Frodl et al., 2008; Savitz and Drevets, 2009], and one that was not a case–control design [Taylor et al., 2011].”
BackgroundLongitudinal associations between BDNF promoter methylation and late-life depression
Kang, H.-J., Kim, J.-M., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Kim, H.-R., Shin, M.-G., & Yoon, J.-S. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.035 · Cited by 65
Colle, R., Gressier, F., Verstuyft, C., Deflesselle, E., Lépine, J.-P., Ferreri, F., Hardy, P., Guilloux, J.-P., Petit, A.-C., Fève, B., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.013 · Cited by 55
“…al., 2013; Domschke et al., 2010; Kocabas et al., 2011; Licinio et al., 2009; Musil et al., 2013; Taylor et al., 2011; Wilkie et al., 2007) patients, especially two 6-month studies (Bukh et al., 2010, Taylor et al., 2011) and the powerful study comprising the STAR-D results (Domschke et al., 2010).”
BackgroundInfluentialMurphy, G. M., Sarginson, J. E., Ryan, H. S., O’Hara, R., Schatzberg, A. F., & Lazzeroni, L. C. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328360b175 · Cited by 50
Yan, T., Wang, L., Kuang, W., Xu, J., Li, S., Chen, J., & Yang, Y. (2014) · Asia-Pacific Psychiatry · doi:10.1111/appy.12148 · Cited by 46
“The interaction between the BDNF genotypes and the treatments’ effect has been reported to be dependent on both the length of treatment and the class of antidepressants (Rajewska-Rager et al., 2008; Domschke et al., 2010; Kang et al., 2010; Taylor et al., 2011).”
BackgroundInfluentialSantos, M., Lima, L., Carvalho, S., Mota-Pereira, J., Pimentel, P., Maia, D., Correia, D., Barroso, M. F., Gomes, S., Cruz, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076758 · Cited by 20
Metadata
- Authors
- Taylor, W. D., McQuoid, D. R., Ashley-Koch, A., MacFall, J. R., Bridgers, J., Krishnan, R. R., & Steffens, D. C.
- Venue
- The Pharmacogenomics Journal
- Published
- 2010-03-02
- Volume
- 11
- Issue
- 2
- Pages
- 146-154
- ISSN
- 1470-269X (ISSN-L)
- 1473-1150
- OpenAlex
- W2110145057
- Cited by
- 50
- References
- 12
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.